The illicit marketplace and linked misuse of prescription drugs has expanded to address alternative substances [1], which include New Psychoactive Substances (NPSs). NPSs comprise a heterogenous team of substances [2], like prescription prescription drugs and research chemical compounds, which aren't managed under the 1961 Solitary Conference on Na